Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Clinical Trial: Copaxone plus Estriol

      A combination trial of Copaxone plus Estriol in relapsing-remitting Multiple Sclerosis. The purpose of this study is to determine if the use of oral Estriol in combination with Copaxone injections is safe; if the use of combination treatment causes a decrease in relapse rates; if there is more rapid improvement on brain MRI with the combination treatment; if there is an improvement in disability measures with the combination treatment. Lebanon, NH

      Lebanon, NH 03756See Map
    2. Clinical Trial: Daclizumab vs Avonex

      The purpose of this study is to compare daclizumab high-yield process (also called DAC HYP) to Avonex in the treatment of relapsing remitting MS. This study will also allow researchers to learn more about the safety of long-term treatment with DAC HYP in patients with MS. Boston, MA

      Boston, MA 02134See Map
    3. Clinical Trial: Natalizumab

      In light of lack of therapy for SPMS patients, the study seeks to determine whether or not Natalizumab is effective in slowing disease progression. Lexington, MA

      Lexington, MA 02421See Map
    4. Local Research Studies and Clinical Trials

      Research studies and clinical trials in the Greater New England area

    5. A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis

      A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis

    6. Research Study: Brain Plasticity

      Seeking patients to participate in a study to test for genes related to disease progression in MS. This is a NON-medication study and requires only one visit. Study participants will complete an MRI (without contrast), a blood-draw for genetic testing, a neurological exam, and brief questionnaires. Lebanon, NH

      Lebanon, NH 03756See Map
    7. An Online Self-Guided Meditation Course for Individuals with Multiple Sclerosis

      Evidence is beginning to show that mind-body work is effective in improving depression, anxiety, fatigue, and balance in individuals with Multiple Sclerosis (MS). This study is designed to evaluate the effectiveness of an 8-week online meditation course in improving cognition, mood, dopamine levels, and quality of life in individuals with MS.

    8. Research Study: Resilience and Health in People with Multiple Sclerosis – an online survey

      Researchers in the Department of Rehabilitation and Movement Science at the University of Vermont are interested in exploring how resiliency differs between individuals with and without multiple sclerosis (MS) and how specific resiliency factors influence health outcomes. The survey should take approximately 20-30 minutes to complete.

    Resources

    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    3. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    4. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    5. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    6. The Other Side of MS Research: Health Policy and Cognition

      Discover the wide range of MS research that impacts quality of life and everyday issues for people with MS. Teleconference recorded December 4, 2013.

    7. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.

Share

Master Page Does Not Exist
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.